Key facts
- This page summarizes Louis H. Morrone's Form 4 filing for ABBOTT LABORATORIES (ABT).
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 01 Jul 2026, 17:04.
Louis H. Morrone - 30 Jun 2026 Form 4 Insider Report for ABBOTT LABORATORIES (ABT)
- Reporting relationship
- EXECUTIVE VICE PRESIDENT
- Issuer ticker
- ABT
- Reported as of
- 30 Jun 2026
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 01 Jul 2026, 17:04:30 UTC
- Prior SEC filing
- 03 Mar 2026
- Source filing
- View source filing
- Reporting owner signature
- /s/ Louis H. Morrone by Jessica H. Paik, Attorney-in-Fact
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Louis H. Morrone filed Form 4 for ABBOTT LABORATORIES (ABT) on 01 Jul 2026.
Change
- Previous filing in this sequence was filed on 03 Mar 2026.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reporting Owners (1)
CIK 0001867666
Primary reporting owner
Morrone Louis H.
- Relationship
- EXECUTIVE VICE PRESIDENT
- Address
- 100 ABBOTT PARK ROAD, ABBOTT PARK
- Signature
- /s/ Louis H. Morrone by Jessica H. Paik, Attorney-in-Fact
- Signature date
- 01 Jul 2026
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
ABT
transaction
Common shares without par value
Tax liability
- Transaction value
- Shares
- -269
- Change %
- -0.35%
- Price
- $92.71*
- Shares after
- 76,574
- Date
- 30 Jun 2026
- Ownership
- Direct
ABT
holding
Common shares without par value
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 12
- Date
- 30 Jun 2026
- Ownership
- Profit Sharing Trust
- Footnotes
- F1
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 1 footnote
Footnote F1
Balance in the Abbott Laboratories Stock Retirement Trust as of June 30, 2026.